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The antibody response to a number of antigens requires the cooperation of at least 
two specific cell  types, namely, thymus-derived lymphocytes (T cells), 1 which have 
helper functions necessary for the stimulation of bone marrow-derived lymphocytes 
(B cells), which are the direct precursors of antibody-producing  cells (1). Each of the 
cell types possesses  specificity for a given antigen since each can be made specifically 
tolerant  (2)  and since cellular suicide resulting from  treatment with  radioactively 
labeled antigen (3) leads to the abolishment of specific immunological activity in each 
cell type (4-6). 
Although both T  cells and B cells can be rendered specifically  unresponsive to an 
antigen, the kinetic pattern of induction, maintenance, and spontaneous loss of toler- 
ance for each is essentially different (7). T cells become tolerant rapidly and remain so 
for a prolonged period whereas the induction of tolerance in B cells requires a greater 
latent period, and the state is maintained for a shorter time. B cells, in addition, re- 
quire a higher dose of antigen for the induction of tolerance than do T cells. Therefore, 
in the case of an antigen for which the immune response requires T-B cell cooperation, 
unresponsiveness in either one of  the two cell populations is sufficient  to make the 
whole animal appear tolerant. 
These data may be extrapolated to form a model for the cellular basis of the nat- 
urally unresponsive state to  those self-antigens present in low concentration within 
the circulation. The hypothesis would be that in these situations, specific T  cells are 
unresponsive whereas specific B  cells are not, and antibody formation cannot occur 
because of the functional T cell deficiency. Accordingly, any event or agent capable of 
rendering the immune response to an antigen independent of the required T cell coop- 
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eration  would  be  expected  to allow the induction  of antibody  formation  to  the tol- 
erated antigen.  Under certain  conditions,  such an  event might  even be expected  to 
result in autoimmunity,  since this phenomenon may be viewed as the termination of 
a  state of natural  tolerance to self-antigens (8). 
Bacterial endotoxins are substances whose biological effects on immunological proc- 
esses may be ideally suited  to permitting a  response  to a  variety of antigens  in the 
absence of a  specific T  helper function. This prediction is based on experimental evi- 
dence demonstrating that endotoxins  (a)  have a  mitogenic effect that is restricted to 
the B  cell population  (9,  10),  (b)  can  substitute  for T  cell function  in  the antibody 
response to sheep erythrocytes, obtained both in vivo (11,  12)  and in vitro (13), and 
(c) can bypass the requirement for T  cells in a hapten carrier system (14). 
The  present  study  will  detail  that,  in  mice,  endotoxin  (ET)  also  possesses 
the capacity to terminate a  state of induced tolerance to human  gamma globu- 
lin  (HGG).  This  phenomenon  can  be  observed  only  at  a  time  when  B  cell 
tolerance has been predictably lost. Moreover, it appears  that during  the spon- 
taneous return from an induced unresponsive  state,  there exists in the tolerant 
animal  a  heightened  antibody-forming  potential,  revealed  by  the  present 
experimental  approach. 
Materials and Methods 
Mice.--A/J male mice, 5 wk old, were purchased from the Jackson Laboratory (Bar Har- 
bor, Maine).  They were housed in groups of five each in covered cages and  maintained  on 
Purina Chow pellets (Ralston Purina Co., St. Louis, Mo.) and chlorinated acidified water (15) 
ad libitum. 
Antigens.--HGG  was  obtained  through  the  courtesy  of  the  American  Red  Cross  and 
prepared  as Cohn Fraction II by E. R. Squibb  & Sons  (New York). Before use,  IgG was 
purified on DEAE-cellulose chromatography  by elution with 0.01 M  phosphate  buffer,  pH 
8.0. DEAE-purified IgG was rendered monomeric by ultracentrifugation (DHGG) at 116,000 g 
for 150 rain in a swinging  bucket rotor (16). The material so prepared will be referred to as a 
tolerogen and its immunological behavior, as tolerogenic (17). To induce tolerance, 6-wk-old 
mice were injected with 2.5 mg of the tolerogen given intraperitoneally in a volume of 1 ml. 
This protocol assures the induction of a complete, specific, and long-lasting state of unrespon- 
siveness in A/J mice (18). 
DEAE-purified IgG was aggregated (AHGG) by heating at 63°C for 25 min and precipitat- 
ing with Na2SO4 (16). The material so obtained evokes an excellent antibody response without 
the need of an adjuvant.  It will be referred to as an immunogen and its immunological be- 
havior, as immunogenic. 
Endotoxin.--The  ET used was the polysaccharide of Escherichia coli 0111 :B4 (lot B35527) 
obtained from Difco Laboratories (Detroit, Mich.). It was diluted to the desired concentration 
in 0.15 M  NaC1. 
Preparations of "B Cell  Mice."--Adult mice were thymectomized (19) and 2-4 wk later were 
lethally irradiated (1,000 R) using a Gammacel140 irradiator (Atomic Energy of Canada, Ltd., 
Ottawa, Ontario, Canada) with a cesium-137 source that emitted a central dose of 115 R/min. 
4-6 h later, each animal was given either 15 >( 106 or 50 )< 106 bone marrow cells that had been 
pretreated  with anti-0  serum and guinea pig complement  (20).  The animals were used for 
experimental purposes a minimum of 30 days after reconstitution. 
Hemolytic Plaque Technique.--Antibody-forming  cells  to HGG or  ET were enumerated 
using modifications of the Jerne plaque assay (21) in which either protein antigens (22) or ET 742  TERMINATION  OF  TOLERANCE  WITH  ENDOTOXIN 
(23) were coupled to goat erythrocytes  (Colorado Serum Co., Denver, Colo.). Indirect plaque- 
forming cells (PFC) weie developed with squirrel monkey antimouse gamma globulin used at 
a concentration previously determined to be optimal in this assay. 
RESULTS 
E~ect of ET on the  Thymic Dependency of the Antibody Response  to HGG in 
Mice.--In mice, the antibody response to HGG is exquisitely dependent on the 
cooperation between  T  and  B  cells.  This  is  best  illustrated  by  the  following 
experiment.  Mice  that  as  adults  were  thymectomized,  irradiated,  and  recon- 
stituted  with  T  cell-deprived  syngeneic bone  marrow  did  not  respond  to  an 
immunogenic challenge of AHGG unless they were given a source of syngeneic 
thymocytes  (Table  I). On  the other  band,  mice  that were similarly  deprived 
TABLE  I 
T Cell Dependency of tlze Response in A/J Mice to HGG 
Treatment  No. of animals 
PFC/106 spleen cells 
Direct  Indirect 
ATX* 
50 X  106 BM~ 
AHGG§  10  0.1  0.2 
ATX 
50 X  106 BM 
90 X  106 T][ 
AHGG  10  0.6  169.3 
* Adult thymectomy, followed 3 wk later by 1,000 R whole body irradiation. 
:~ Syngeneic bone marrow cells treated  with anti-0 serum and complement. 
§ Aggregated HGG given intravenously  (i.v.) on day 0, intraperitoneally  (i.p.) on day 10; 
PFC determined 5 days after the last injection. 
]1 Syngeneic thymocytes. 
of T  cells did respond to HGG if, in addition to the antigen, they also received 
ET  (Table II). It should be pointed out that  although the response obtained 
in  Table  I  is  greater  than  that  seen  in  Table  II,  a  quantitative  comparison 
between the two is not valid, inasmuch as each set of animals received a differ- 
ent inoculum of bone marrow cells: 50 X  106 and 15  X  106, respectively. Nev- 
ertheless,  these experiments  clearly demonstrate  that  the  thymus dependency 
of the response in mice to HGG can be overcome by the use of ET. 
Termination  of  Tolerance  with  Immunogen  and  ET.--The  capacity  of  ET 
to render the response to HGG independent of T  cells should allow the termi- 
nation of a tolerant state when tolerance is maintained solely by the unrespon- 
siveness  of a  specific T  cell population,  a  cellular  state  that  exists in animals 
50 or 60 days after  the  single injection  of a  tolerogenic preparation  of HGG. 
This  prediction  was  fulfilled,  as  seen  in  the  following  experiment.  Normal JACQUES  M.  CHILLER  AND  WILLIAM  O.  WEIGLE  743 
TABLE  II 
Effect  of ET on the Response of A TXBM* Mice to AHGG 
PFC/spleen 
Treatment  No. of mice 
Direct  Indirect 
AHGG:~  6  35  87 
AHGG +  ET§  6  434  5,510 
*  ATXBM:  adult  mice, thymectomized,  irradiated,  and  reconstituted  with  15  X  l0  s 
anti-0-treated  bone marrow ceils. 
:~ 400 #g of aggregated HGG given i.v. on days 0 and 8 and i.p. on day 15. Spleens are 
assayed for PFC on day 20. 
§ 400 #g of aggregated  HGG and 10 #g of ET given i.v. on days 0 and 8, and 400 #g 
of aggregated HGG alone given i.p. on day 15. Spleens were assayed for PFC on day 20. 
mice or mice injected  with  2.5  mg of tolerogen 90 days previously were each 
given one of the following three  regimens:  (a)  50/zg of ET intravenously on 
day 0, 25 #g of ET intravenously on day 6; (b) 400/~g of AHGG intravenously 
on both days 0  and 6; (c)  400 #g of AHGG +  50 #g of ET intravenously on 
day 0  and 400/~g of AHGG +  25 #g of ET intravenously on day 6.  5  days 
after the second injection, each group was assayed for PFC specific to HGG. 
It can be  seen  in Table  III that  the  combination of both  the  immunogen 
AHGG and  the ET does in fact terminate  the  tolerant  state,  although either 
one of these substances given alone does not. It is both striking and significant 
that the response so obtained in tolerant mice is higher than that observed in 
normal animals that had received AHGG, either alone or with ET. 
The response to HGG obtained in the tolerant mice is specific to HGG and 
is  not due  to an immunological  response  to ET producing a  cross-reaction in 
the assay system used to detect anti-HGG PFC. This is made clear by the data 
seen in Table IV, in which the response of tolerant mice given AHGG and ET 
was assayed for PFC to HGG or to ET and the specificity of antibody-forming 
cells was verified by inhibition experiments.  In all three examples, spleens from 
tolerant  mice contained both PFC  to HGG and PFC  to ET.  However,  PFC 
to HGG were inhibited with HGG, but not ET, when either was incorporated 
as free antigen in the agar. Similarly, PFC to ET were inhibited with ET, but 
not with HGG. 
Termination of Tolerance with Immunogen and ET. Demonstration of ttyper- 
immune Potential in Tolerant Animals.--A more striking example of the height- 
ened  resoonse  obtained  in  tolerant  animals  given  AHGG  and  ET  is  seen  in 
Table  V. Mice that had received 2.5  mg of DHGG  143  days previously were 
injected twice with either AHGG or AHGG and ET, by the protocol described 
in Table IV. The response of tolerant  animals  that received both AHGG and 
ET was some eightfold greater than that obtained in normal animals that had 
been similarly challenged. On the other hand, tolerant animals given only HGG 
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TABLE  III 
Termination  of Tolerance in Mice with a Combination  of AHGG and PiT 
Group  Treatment*  No. of mice  Indirect PFC/10a  spleen cells 
Normal  ET ~  6  0.2 
Normal  AHGG§  6  44.5 
Normal  AHGG +  ET  6  54.1 
TolerantH  ET  6  0.3 
Tolerant  AHGG  6  9.3 
Tolerant  AHGG +  ET  6  93.8 
* Each group received the first injection (0.3  ml) on day 0 and the second injection (0.15 
ml) on day 6; both were given i.v., and PFC specific to HGG were determined 5 days after 
the last injection. 
:~ 50 and 25 ~zg in the first and second injections, respectively. 
§ 400 ~zg for both first and second injections. 
II Mice used 90 days after the injection of 2.5 mg of DHGG. 
TABLE  IV 
Specificity  of PFC Obtained to  HGG  in  Tolerant  Mice  after the Injection of AHGG and  ET 
Animal no.*  Inhibitor$ 
Indirect PFC/spleen 
To HGG  To ET 
None  14,450  19,484 
HGG  0  20,428 
ET  14,922  0 
None  12,790  1,635 
HGG  96  1,694 
ET  12,743  93 
None  15,608  4,394 
HGG  0  4,518 
ET  16,228  0 
* Mice treated 90 days previously with 2.5 mg of DHGG were injected i.v. with 400/~g 
of AHGG +  50/zg of ET on day 90 and 200/~g of AHGG +  25 #g of ET on day 96. Splenic 
PFC to HGG or ET were determined 5 days after the last injection. 
* Added at a final concentration of 7.5 gg/ml in the agar. 
In  addition,  the  data  presented  in Table V  demonstrate  that  the  ability of 
the dual treatment  with immunogen  and ET  cannot terminate a  state of toler- 
ance  in  mice  25  days  after  the  injection  of  the  tolerogen.  These  data  are  in 
keeping with the fact that  at this time B  cells are tolerant, 2 so that the ability 
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of ET to allow a  bypass of T  cell helper activity is inconsequential in the ab- 
sence of specific B  cell function. 
Before and  during  the  experiments presented  above,  it had  been  observed 
that the immunogenic challenge of adoptively transferred spleen cells obtained 
from mice  long  after  tolerogen injection  (> 100  days)  sometimes  resulted  in 
responses twofold to sixfold higher than those obtained with the similar trans- 
fer of spleen cells from normal animals. One such experiment is represented in 
Table V1.  Spleen cells (75  X  10 ~)  obtained from either normal mice or mice 
treated with 2.5 mg of DHGG  120 days previously were injected intravenously 
into lethally irradiated (1,000  R)  syngeneic hosts.  At this time, and again  10 
days later, each recipient was  challenged with 400  #g  of AHGG given intra- 
venously and  intraperitoneally, respectively; and  5  days after  the second in- 
jection,  they were  assayed for  splenic PFC  specific to  HGG.  It  can  be  seen 
TABLE V 
Comparison of the Effect of ET on the Response of Normal Mice 25 and 143 Days after Tolerogen 
Injection 
Group  Treatment*  No. of mice  Indirect  PFC/spleen 
Normal  AHGG:~  7  7,314 
Normal  AHGG +  ET§  7  8,856 
Day 25 tolerantll  AHGG  7  502 
Day 25 tolerant  AHGG d- ET  7  788 
Day 143 tolerant¶  AHGG  6  1,803 
Day 143 tolerant  AHGG q- ET  6  60,480 
* Each group received the first injection (0.3 ml) on day 0 and the second injection (0.15 
ml) on day 6; both were given i.v. and PFC specific to HGG were determined 5 days after 
the last injection. 
:~ AHGG, 400 #g for first injection and 200 #g for second injection. 
§ ET, 50/zg for first injection and 25 #g for second injection. 
II Mice used 25 days after the injection of 2.5 mg of deaggregated HGG. 
¶ Mice used 143 days after the injection of 2.5 mg of deaggregated HGG. 
TABLE VI 
Hyperresponsiveness in Adoptively  Transferred Spleen  Cells Obtained from Mice 120 Days after 
the Injection  of Tolerogen 
Indirect  PFC/106  Ratio  (tolerant/  Group  No. of mice  spleen cells  normal) 
cells*  11  206 
6.1 
9  34 
8  31  0.14  8  227 
Tolerogen-treated  spleen 
(75 ×  106) 
Normal spleen cells (75 X  106) 
Tolerogen-treated donors 
Normal donors 
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that under  those  experimental conditions,  spleen  cells from tolerogen-treated 
animals responded six times better than did normal spleen cells.  In contrast, 
animals  from the  same  donor  groups  challenged  twice  with  immunogen  be- 
haved as might be expected, that is, their response was seven times less than 
that of normal mice. 
DISCUSSION 
The ability of bacterial  ET to induce  responsiveness to antigens in  the ab- 
sence of a specific T  cell helper function also allows the immunological circum- 
vention of a state of tolerance for which the cellular basis is restricted to spe- 
cific T  cell unresponsiveness.  In the present studies it has been demonstrated 
that in mice, the T  cell-dependent antibody response to HGG can be made T 
cell  independent  if,  in  addition  to  immunogen,  ET  is  part  of  the  injection 
protocol. In the same manner, the state of induced tolerance to HGG, present 
at a  time when B cells have lost their unresponsiveness, can be terminated by 
the  injection  of both  aggregated HGG and  ET,  but  by neither  given  alone. 
Furthermore, there is no effect on HGG tolerance when this regimen is followed 
at a time when B cells are still tolerant. 
The mode of action by which ET can substitute for T  cell helper function is 
not known. It may be that the B  cell mitogenic activity of ET (9,  10) coupled 
with the specific interaction of antigen to B cell receptors is sufficient to initiate 
cellular  differentiation  and  proliferation,  processes  that  normally  antigen 
alone cannot  mediate  without  T  cell  help.  The  adjuvant  action  of antibody 
formation attributable to ET (24)  may be partly dependent on this mitogenic 
effect. The potent immunogenicity of Salmonella 0  antigen,  which,  as Nossal 
and Ada (25)  point out, is 11  orders of magnitude greater than that of serum 
protein  antigens  and 7 orders greater than  that of pneumococcal polysaccha- 
rides, may also be related to the presence of a mitogenic moiety that, if coupled 
to an  antigenic  determinant  on  the  same molecule, is capable of specific cell 
stimulation at an extremely low threshold of antigen concentration. 
The  present  data,  therefore,  provide  evidence  for  a  mechanism by which 
induced  tolerance  maintained  by  the  functional  absence  of  specific  T  cells 
may  be  readily  terminated.  Other  pathways  for  the  early  termination  of 
tolerance have been described previously; all appear dependent on the ability 
to bypass the block created by specific T  cell tolerance. For example, the ability 
to terminate tolerance with either altered (26)  or cross-reacting albumins (27) 
is most probably due to the participation of nontolerant T  cells stimulated by 
unrelated  determinants  on  the  altered  or  cross-reacting  molecule.  The  same 
phenomenon  can  be  more  directly  demonstrated  by  the  ability  to  obtain  a 
specific response in a tolerant animal when the tolerated antigen is coupled to a 
nontolerated  carrier  (28).  The cellular basis for these phenomena is probably 
identical  with  that operational  in  the  ability to  overcome genetic  unrespon- 
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molecules  (29).  It  is  of interest  that  antibody formation to HGG in  a  low- 
responding strain can be elevated by the use of  ET to the level obtained  in 
a  high-responding strain, ~ a  phenomenon in accord with the finding that  the 
frequency of specific antigen-binding cells (B cells) is identical in both strains3 
The hyperresponsiveness to HGG observed in spleen cells  after the loss of 
tolerance in B  cells is not clearly understood, although the paradox of height- 
ened reactivity to antigenic challenge after recovery from tolerance has been 
well documented previously (30, 31). Theoretical considerations of the present 
studies must incorporate the observations that during the recovery from toler- 
ance  (a)  the injection of antigen plus  ET can  terminate  tolerance and  even 
produce hyperresponsiveness, (b)  the injection of syngeneic cells  2 and/or anti- 
gen can do neither, (c) the adoptive transfer of tolerant cells and antigen into 
irradiated  recipients  sometimes results  in  a  much  greater  response  than  do 
transferred normal cells, and (d) thymus cells remain unresponsive (7). 
It may be that in the animal, a level of tolerogen below the threshold needed 
to induce tolerance in newly differentiating clones of B  cells may be able to 
prime those cells by a molecular model analogous to that proposed by Diener 
and Feldmann (32). They postulated that the difference between the immuno- 
genic  and  tolerogenic properties  of  antigenic  determinants  is  a  function  of 
epitope density. For example, the degree of substitution of the dinitrophenol 
(DNP) hapten per unit of monomeric flagellin affects the in vitro response to 
DNP, in that lightly substituted flagellin induces antibody formation whereas 
heavy substitution induces a specific unresponsiveness (33). A priming effect of 
precursor cells by subtolerogenic quantities of HGG may induce differentiation 
and/or proliferation of specific cells whose commitment to antibody formation 
would still require a T cell helper function (34). However, the antibody-forming 
potential could be revealed by the ability of ET to circumvent the T  cell re- 
quirement.  When  such  primed  cells  along with  antigen  are  transferred to  a 
syngeneic irradiated host,  their immunological potential may be expressed if 
T  cell tolerance wanes as a result of transfer to a neutral environment or if the 
recipient animal  can provide a  minimal  quantity of helper function whether 
it be cellular, cellular ~actors (35), or even ET released from a gram-negative 
bacterial  infection after postirradiation  stress.  Since,  in  this  irradiation  en- 
vironment, a  selective advantage for the replication of specifically stimulated 
cells (36)  relative to nonprimed cells could be expected, activated primed cells 
might be expected to be amplified, providing the data presented above. 
Bacterial ET could theoretically play a role in the circumvention of natural 
tolerance to self-antigens if the cellular basis for the naturally unresponsive state 
to  self-antigens present  in  low  circulating  levels is  the  same  as  the  cellular 
basis of tolerance obtained using low doses of antigen to induce tolerance (7). 
It  seems  that  under  these  conditions,  specific tolerance can be induced  and 
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maintained in T  ceils,  but not in B  cells; and expression of immunity cannot 
occur only because of functional T  cell deficiency. Thus any means that renders 
the response independent of the cooperation with those specific T  cells would 
be expected to permit specific antibody formation to a self-antigen. 
As in those studies described above for the termination of induced tolerance 
to serum albumins, the natural tolerance to rabbit thyroglobulin in the rabbit 
can be terminated by injecting immunologically cross-reacting thyroglobulins 
(37),  chemically modified  thyroglobulins  (38),  or  complexes of  heterologous 
antibody and rabbit thyroglobulin (28). These data support the hypothesis that 
thyroiditis  may be  induced  because  the  circulating  concentrations  of  thyro- 
globulin that reach immunocompetent B  cells are too low to induce a tolerant 
state in those cells,  although they are sufficient to render specific T  cells toler- 
ant.  The presence of immunocompetent B  cells specific for autologous thyro- 
globulin in mice (39)  is compatible with this conclusion. 
Inasmuch  as  the  physiological  state  of  restricted  cell  tolerance  to  certain 
self-antigens mirrors what occurs after the spontaneous loss of B  cell  tolerance 
in mice to HGG, it may be subject to the same ET-mediated termination de- 
scribed  in  the  present  studies.  This  is  not  to  imply that  the  immunological 
consequences of a gram-negative infection will  always result in autoimmunity, 
but rather to suggest that under the appropriate temporal release of sufficient 
self-antigen  and  bacterial products,  the  homeostatic balance of self-tolerance 
could be altered. 
SUMMARY 
Bacterial lipopolysaccharides (endotoxin)  allowed the circumvention of  the 
thymus-derived  (T)  cell  helper function  otherwise required  for the  antibody 
response in mice to human gamma globulin  (HGG). In an analogous  fashion, 
the state of tolerance to HGG, existing at a time when bone marrow-derived (B) 
cells had lost their unresponsiveness,  could be terminated by the injection of 
both immunogenic HGG and endotoxin, but by neither given alone. However, 
no effect on tolerance to HGG could be observed when  this regimen was fol- 
lowed  at  a  time when  B  cells were  tolerant.  After  the  spontaneous  recovery 
from tolerance in B cells,  it seemed that specific priming was occurring in that 
population. This phenomenon was observed either by the injection of endotoxin 
and HGG or by the adoptive transfer of cells into irradiated hosts. These data 
have been discussed in the light of potential autoimmune manifestations that 
could  theoretically  follow  a  simultaneous  gram-negative  bacterial  infection 
along with a release of self-antigen. 
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Habicht for helpful criticism of the manuscript. 
REFERENCES 
1.  Mitchell, G. F., and J. F. A. P. Miller.  1968. Cell to cell interaction in the immune 
response. II. The source of hemolysin-forming cells in irradiated mice given bone 
marrow and thymus or thoracic duct tymphocytes. J. Exp. Med. 19.8:821. JACQUES M.  CHILLER AND  WILLIAM O.  WEIGLE  749 
2.  Chiller, J. M., G. S. ttabicht, and W. O. Weigle. 1970. Cellular sites of immuno- 
logic unresponsiveness. Proc. Natl. Acad. Sci.  U.S.A. 65:551. 
3.  Ada, G. L., and P. Byrt. 1969. Specific inactivation of antigen reactive cells with 
l~SI-labelled antigen. Nature (Lond.). 222:1291. 
4.  Basten, A., J. F. A. P. Miller, N. L. Warner, and J. Pye. 1971. Specific inactiva- 
tion of thymus-derived (T) and non-thymus-derived (B)  lymphocytes by 125I- 
labelled antigen. Nat. New Biol. 231:104. 
5.  Roelants, G. E., and B. A. Askonas. 1971. Cell cooperation in antibody induction. 
The susceptibility of helper cells to specific lethal radioactive antigen. Fur. J. 
lmmunol.  1:151. 
6.  Unanue, E. R. 1971. Antigen binding cells. II. Effect of highly radioactive antigen 
on the immunologic function of bone marrow cells. J. Immunol. 107:1663. 
7.  Chiller, J. M., G. S. Habicht, and W. O. Weigle. 1971. Kinetic differences  in un- 
responsiveness of thymus and bone marrow cells. Science (Wash. D.C.). 171:813. 
8.  Weigle, W. O.  1971. Recent observations and  concepts in immunological unre- 
sponsiveness and autoimmunity. Clin. Exp. Immunol.  9:437. 
9.  Gery, I., J.  Krtiger,  and  S. Z.  Spiesel.  1972. Stimulation  of B  lymphocytes by 
endotoxin. Reactions of thymus-deprived mice and karyotypic analysis of di- 
viding cells in mice bearing T6T6 thymus grafts. J. Immunol.  108:1088. 
10.  Andersson, J., G. MSller,  and O. SjSberg.  1972. Selective induction of DNA syn- 
thesis in T  and B lymphocytes. Cell Immunol. 4:381. 
11~  Jones, J. M., and P. D. Kind.  1972. Enhancing effect of bacterial endotoxins on 
bone marrow cells in the immune response to SRBC. J. [mmunol. 108:1453. 
12.  MSller,  G., J. Andersson, and O. SjSberg.  1972. Lipopolysaccharides can convert 
h~terologous red ceils into thymus-independent antigens.  Cell Immunol. 4:416. 
13.  SjOberg, O., J. Andersson, and G. MS'_ler. 1972. Lipopolysaccharides can substi- 
tute for helper cells in the antibody response in vitro. Eur. J. Immunol. 2(4):326. 
14.  Schmidtke, J., and F. J. Dixon. 1972. Immune response to a hapten coupled to a 
nonimmunologic carrier. Influence of lipopolysaccharide. J. Exp. Med. 136"392. 
15.  McPherson, C. W. 1963. Reduction of Pseudomonas aeruginosa  and coliform bac- 
teria  in mouse drinking water  following treatment  with hydrochloric acid or 
chlorine. Lab. Anita. Care. 13(5):737. 
16.  Chiller, J.  M., and W. O. Weigle.  1971. Cellular events during induction of im- 
munological unresponsiveness in adult mice. J. Immunol.  106:1647. 
17.  Dresser, D. W. 1962. Specific inhibition of antibody production. II. Paralysis in- 
duced in adult mice by small quantitites of protein antigen. Immunology. 5:378. 
18.  Chiller, J. M., and W. O. Weigle.  1971. Cellular basis of immunological unrespon- 
siveness.  In Contemporary Topics of Immunobiology. M. G. Hanna, Jr., editor. 
Plenum Publishing Corp., New York. 1:119. 
19.  Miller, J. F. A. P.  1960. Studies on mouse leukemia. The role of the thymus in 
leukemogenesis by cell-free leukemia filtrates. Br. J. Cancer.  10:431. 
20.  van Boxel, j. A., J. O. Stobo, W. E. Paul, and I. Green. 1972. Antibody-dependent 
lymphoid  cell-mediated  cytotoxicity:  No  requirement  for  thymus-derived 
lymphocytes. Science (Wash. D.C.). 175"194. 
21.  Jerne, N. K., and A. A. Nordin. 1963. Plaque formation in agar by single antibody- 
producing cells. Science (Wash. D.C.). 140:405. 
22.  Golub, E. S., R. I. Mishell, W. O. Weigle, and R. W. Dutton. 1968. A modification 750  TERMINATION OF  TOLERANCE  WITH  ENDOTOXIN 
of the hemolytic plaque assay for use with protein antigens. J. Immunol. 100: 
133. 
23.  Rudbach, J. A.  1971. Molecular immunogenicity of bacterial lipopolysaccharide 
antigens: establishing a quantitative system. J. Immunol. 106:993. 
24.  Johnson, A. G.  1964. The adjuvant action of bacterial endotoxins on the primary 
antibody response. In Bacterial Endotoxins. M. Landy and W. Braun, editors. 
Rutgers University Press, New Brunswick, N. J. 252. 
25.  Nossal, G. J. V., and G. L. Ada. 1971. In Antigens, Lymphoid Cells and the Im- 
mune Response. F. J. Dixon and H. G. Kunke], editors. Academic Press, Inc., 
New York. 245. 
26.  Weigle, W. O.  1962. Termination of acquired immunological tolerance to protein 
antigens following immunization with altered  protein  antigens.  J. Exp. Med. 
116:913. 
27.  Weigle, W. O.  1961. The immune response of rabbits  tolerant  to bovine serum 
albumin  to the injection of other heterologous serum albumins. J. Exp. Med. 
114:111. 
28.  Habicht, G. S., J. M. Chiller, and W. O. Weigle.  1972. Termination of immuno- 
logical unresponsiveness using tolerated antigen complexed with antibody. Fed. 
Proc. 31:773. (Abstr.) 
29.  Benacerraf,  B.,  and  H.  O.  McDevitt.  1972. Histocompatibility-linked  immune 
response genes. Science (Wash. D.C.). 175:273. 
30.  Terres, G., and W. H. Hughes. 1959. Acquired immune tolerance in mice to crys- 
talline bovine serum albumin. J. Immunol. 83:459. 
31.  Thorbecke, G. J., G. W. Siskind,  and N. Goldberger. 1961. The induction in mice 
of sensitization  and  immunological unresponsiveness  by neonatal  injection of 
bovine gamma globulin. J. lmmunol. 87:147. 
32.  Diener, E., and M. Feldmann.  1972. Relationship between antigen and antibody 
induced suppression of immunity. Transplant. Rev. 8:76. 
33.  Feldmann,  M.  1972.  Induction of immunity and  tolerance  in  vitro  by hapten 
protein conjugates. I. The relationship between the degree of hapten conjuga- 
tion and the immunogenicity of dinitrophenylated polymerized flagellin. J. Exp. 
Med. 135:735. 
34.  Roelants, G. E., and B. A. Askonas.  1972. Immunological B memory in thymus 
deprived mice. Nat. New Biol. 239:63. 
35.  Katz, D. H., and B.  Benacerraf.  1972. The regulatory influence  of activated T 
lymphocytes on B cell responses to antigen. Adv. Immunol. 15:1. 
36.  Dixon, F. J., and P. J. McConahey. 1963. Enhancement of antibody formation by 
whole body X-radiation. J. Exp. Med. 117:833. 
37.  Weigle,  W. O., and  R.  M.  Nakamura.  1967. The development of autoimmune 
thyroiditis in rabbits following injection of aqueous preparation of heterologous 
thyroglobulins. J. lmmunol. 99:223. 
38.  Weigle, W. O.  1965. The production of thyroiditis and antibody following injec- 
tion of unaltered thyroglobulin without adjuvant into rabbits previously stimu- 
lated with altered thyroglobulin. J. Exp. Med.  122:1049. 
39.  Clagett, J. A.  1972. Cellular collaboration and  specificity in murine  thyroiditis. 
Fed. Proc. 31:743. (Abstr.) 